Posted by Michael Wonder on 06 Jan 2023
Pear Therapeutics and Spero Health to expand access to prescription digital therapeutics for people in recovery across multiple locations and states
4 January 2023 - Spero Health, one of the nation’s largest office-based outpatient opioid treatment providers for individuals in recovery, to expand patient access to Pear’s prescription digital therapeutics for the treatment of substance use disorder and opioid use disorder.
Pear Therapeutics today announced the expansion of its collaboration with Spero Health, an integrated health care services organisation specialising in local and affordable outpatient care for individuals suffering from substance use disorders, to provide adults suffering from substance use disorder and opioid use disorder access to reSET and reSET-O, for each respective condition.
